The Pennsylvania Superior Court has sent a Risperdal case that initially came to a $1.75 million verdict back to the trial court to determine whether there should be a new trial on punitive damages.

A three-judge Superior Court panel on Tuesday issued its ruling in Murray v. Janssen Pharmaceuticals, which was the third case to go to trial from the Risperdal mass tort program in Philadelphia. The case had initially come to a $1.75 million verdict, which was later reduced by the trial court to $680,000.